Literature DB >> 12805412

Review of the in vivo functions of the p160 steroid receptor coactivator family.

Jianming Xu1, Qingtian Li.   

Abstract

The p160 steroid receptor coactivator (SRC) gene family contains three homologous members, which serve as transcriptional coactivators for nuclear receptors and certain other transcription factors. These coactivators interact with ligand-bound nuclear receptors to recruit histone acetyltransferases and methyltransferases to specific enhancer/promotor regions, which facilitates chromatin remodeling, assembly of general transcription factors, and transcription of target genes. This minireview summarizes our current knowledge about the molecular structures, molecular mechanisms, temporal and spatial expression patterns, and biological functions of the SRC family. In particular, this article highlights the roles of SRC-1 (NCoA-1), SRC-2 (GRIP1, TIF2, or NCoA-2) and SRC-3 (p/CIP, RAC3, ACTR, AIB1, or TRAM-1) in development, organ function, endocrine regulation, and nuclear receptor function, which are defined by characterization of the genetically manipulated animal models. Furthermore, this article also reviews our current understanding of the role of SRC-3 in breast cancer and discusses possible mechanisms for functional specificity and redundancy among SRC family members.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805412     DOI: 10.1210/me.2003-0116

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  163 in total

1.  Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes.

Authors:  Jian Yang; Chunshu Hao; Dongfang Yang; Deshi Shi; Xiulong Song; Xiaofei Luan; Gang Hu; Bingfang Yan
Journal:  Toxicol Lett       Date:  2010-06-09       Impact factor: 4.372

2.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

3.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 4.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets.

Authors:  David M Lonard; Bert W O'Malley
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

5.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

Review 6.  Coactivator recruitment: a new role for PAS domains in transcriptional regulation by the bHLH-PAS family.

Authors:  Carrie L Partch; Kevin H Gardner
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

7.  Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription.

Authors:  Dennis J Chia; Jennifer J Young; April R Mertens; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-02-16

8.  Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines.

Authors:  Olivia Tania Hernández-Hernández; Mauricio Rodríguez-Dorantes; Aliesha González-Arenas; Ignacio Camacho-Arroyo
Journal:  Endocrine       Date:  2009-12-05       Impact factor: 3.633

9.  Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.

Authors:  Arthur C-K Chung; Suoling Zhou; Lan Liao; Jean Ching-Yi Tien; Norman M Greenberg; Jianming Xu
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

10.  GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression.

Authors:  Yurii Chinenov; Maria A Sacta; Anna R Cruz; Inez Rogatsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.